HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tomoaki Murakami Selected Research

Congo Red

2/2023Identification of Ameloblastin as an Amyloid Precursor Protein of Amyloid-Producing Ameloblastoma in Dogs and Cats.
1/2022Systemic amyloidosis derived from EFEMP1 in a captive Tsushima leopard cat.
1/2020Pathology and Proteomics-Based Diagnosis of Localized Light-Chain Amyloidosis in Dogs and Cats.
11/2016Experimental transmission of systemic AA amyloidosis in autoimmune disease and type 2 diabetes mellitus model mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tomoaki Murakami Research Topics

Disease

43Macular Edema
03/2024 - 08/2006
27Diabetic Retinopathy (Retinopathy, Diabetic)
05/2023 - 03/2005
26Retinal Vein Occlusion
03/2024 - 08/2006
20Amyloidosis
02/2024 - 09/2011
11Amyloid Plaque
02/2024 - 03/2012
9Retinal Detachment (Retinal Detachments)
05/2023 - 02/2011
7Heart Failure
01/2018 - 05/2002
6Neoplasms (Cancer)
01/2023 - 09/2012
5Congenital Heart Defects (Congenital Heart Defect)
05/2019 - 03/2004
4Hemorrhage
02/2024 - 01/2015
4Vision Disorders (Hemeralopia)
09/2023 - 01/2013
4Aneurysm (Aneurysms)
01/2023 - 12/2015
4Fibrosis (Cirrhosis)
07/2021 - 03/2015
4Inflammation (Inflammations)
11/2020 - 10/2015
4Epiretinal Membrane (Epiretinal Membranes)
07/2015 - 09/2011
3Microaneurysm
05/2023 - 02/2011
3Vitreous Detachment (Posterior Vitreous Detachment)
01/2022 - 10/2007
3Infections
11/2020 - 09/2011
3Hypertension (High Blood Pressure)
01/2020 - 02/2007
3Type 2 Diabetes Mellitus (MODY)
01/2019 - 11/2016
3Retinal Neovascularization
12/2006 - 08/2005
2Vitreous Hemorrhage
02/2024 - 07/2015
2Wounds and Injuries (Trauma)
01/2024 - 01/2019
2Alzheimer Disease (Alzheimer's Disease)
12/2023 - 10/2023
2Carcinoma (Carcinomatosis)
11/2023 - 01/2023
2Diabetic Angiopathies (Diabetic Angiopathy)
05/2023 - 01/2017
2Retinal Arterial Macroaneurysm
03/2022 - 09/2021
2Pathologic Constriction (Stenosis)
01/2021 - 10/2017
2Cerebral Infarction
01/2021 - 12/2019
2Neuroinflammatory Diseases
01/2019 - 01/2019
2Proteostasis Deficiencies
11/2016 - 01/2015
2Bacterial Infections (Bacterial Infection)
10/2015 - 06/2013
2Aortic Coarctation
03/2015 - 12/2008
2Microcephaly
05/2014 - 04/2014
2Tetralogy of Fallot (Fallot Tetralogy)
02/2012 - 04/2005
2Ischemia
09/2007 - 08/2005
2Pathologic Neovascularization
09/2007 - 01/2006
2Pulmonary Artery Stenosis
02/2006 - 04/2005
1Lordosis
05/2024
1Vascular Diseases (Vascular Disease)
02/2024
1Intracranial Aneurysm (Cerebral Aneurysm)
02/2024
1Familial Amyloidosis (Hereditary Amyloidosis)
02/2024
1Suppurative Otitis Media
07/2023
1Ameloblastoma
02/2023
1Thrombosis (Thrombus)
01/2023
1Intracranial Sinus Thrombosis (Sinus Thrombosis)
01/2023

Drug/Important Bio-Agent (IBA)

43Retinaldehyde (Retinal)IBA
02/2024 - 08/2005
22Amyloid (Amyloid Fibrils)IBA
12/2023 - 03/2012
19Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2024 - 03/2005
12Ranibizumab (Lucentis)FDA Link
05/2022 - 01/2015
12AA amyloidosisIBA
06/2021 - 09/2011
9Fluorescein (Funduscein)FDA LinkGeneric
05/2023 - 12/2010
9Biomarkers (Surrogate Marker)IBA
05/2023 - 03/2015
9Proteins (Proteins, Gene)FDA Link
02/2023 - 09/2015
6N-acetyltryptophanamide (NATA)IBA
03/2024 - 01/2017
4Congo RedIBA
02/2023 - 11/2016
4Amyloidogenic ProteinsIBA
01/2022 - 09/2011
4Tissue Plasminogen Activator (Alteplase)FDA Link
04/2009 - 08/2006
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2021 - 01/2018
3AntioxidantsIBA
04/2019 - 10/2017
3TolvaptanFDA Link
02/2016 - 06/2013
3Bevacizumab (Avastin)FDA Link
10/2012 - 11/2010
2Peptides (Polypeptides)IBA
11/2023 - 03/2015
2Keratins (Keratin)IBA
01/2023 - 03/2020
2SteroidsIBA
01/2021 - 09/2013
2Acute-Phase Proteins (Acute-Phase Protein)IBA
11/2020 - 11/2016
2Serum Amyloid A Protein (Serum Amyloid A)IBA
11/2020 - 11/2016
2VimentinIBA
03/2020 - 09/2012
2AutoantibodiesIBA
01/2019 - 01/2019
2Fibroins (Fibroin)IBA
11/2017 - 11/2016
2Vasopressins (Vasopressin)IBA
02/2016 - 06/2013
2Coenzyme A (CoA)IBA
03/2015 - 12/2008
2Methylnitrosourea (N-Methyl-N-nitrosourea)IBA
05/2014 - 04/2014
2Alkylating AgentsIBA
05/2014 - 04/2014
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
06/2013 - 02/2012
2Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
09/2007 - 08/2005
2ErythropoietinFDA Link
09/2007 - 08/2005
1Apolipoprotein C-IIIIBA
02/2024
1Fibrin Tissue Adhesive (Fibrin Sealant)IBA
01/2024
1tau Proteins (tau Protein)IBA
12/2023
1Calcitonin Receptors (Calcitonin Receptor)IBA
11/2023
1AntibodiesIBA
02/2023
1Fibrinogen (Factor I)FDA Link
01/2023
1apolipoprotein A-IV (apolipoprotein AIV)IBA
01/2023

Therapy/Procedure

12Therapeutics
02/2024 - 05/2012
10Injections
05/2022 - 12/2016
7Lasers (Laser)
01/2022 - 06/2014
6Vitrectomy
01/2022 - 09/2012
5Aftercare (After-Treatment)
03/2022 - 01/2011
4Thrombectomy
01/2023 - 12/2015
3Catheters
05/2024 - 02/2006
3Traction
02/2024 - 09/2011
3Stents
01/2023 - 04/2005
2Length of Stay
02/2024 - 03/2004
2Intravitreal Injections
01/2018 - 04/2009
2Fontan Procedure (Fontan Operation)
01/2018 - 02/2006
1Rejuvenation
02/2024
1Telescopes
09/2023
1Middle Ear Ventilation (Tympanostomy)
07/2023
1General Anesthesia
01/2023